Characteristics of 'super responders' and 'super nonresponders' to first biologic monotherapy for psoriasis: a nested case-control study

Br J Dermatol. 2024 Feb 16;190(3):441-444. doi: 10.1093/bjd/ljad446.
No abstract available

MeSH terms

  • Biological Products* / therapeutic use
  • Case-Control Studies
  • Humans
  • Psoriasis* / drug therapy
  • Treatment Outcome

Substances

  • Biological Products